Form 4: Integra LifeSciences Executive Sells 1,700 Shares

Michael J. McBreen, an executive at Integra LifeSciences, sold 1,700 shares of common stock at a price of $24.155 per share on December 2, 2024.

Summary

• Michael J. McBreen, an Executive Vice President and President of CSS at Integra LifeSciences, sold 1,700 shares of the company's common stock on December 2, 2024.
• The sale was executed at a price of $24.155 per share.
• Following the transaction, Mr. McBreen directly owns 56,182 shares of Integra LifeSciences common stock.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by an executive, which is neither positive nor negative for the company's overall outlook.

Industry Context

Executive stock sales are a common occurrence and are often part of compensation packages or personal financial planning. This transaction is not unusual for a company of this size.

Comparison to Industry Standards

• Executive stock sales are a normal part of corporate activity and are common across the industry.
• It is typical for executives to have a mix of salary, stock options, and restricted stock units as part of their compensation.
• The sale of 1,700 shares is not a significant amount compared to the total outstanding shares of the company.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or financial health.

Key Dates

Keywords

Integra LifeSciences, IART, stock sale, executive transaction, insider trading, Form 4, Michael J. McBreen